Janssen’s psoriasis biologic Tremfya shows long-term effect

19th February 2018 Uncategorised 0

Top-line trial data unveiled by Janssen at the 2018 American Academy of Dermatology (AAD) Annual Meeting over the weekend indicate that the benefit of Tremfya in patients with severe plaque psoriasis is maintained in the long-term.

More: Janssen’s psoriasis biologic Tremfya shows long-term effect
Source: News